These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14612150)

  • 1. Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter.
    Bonnet JJ
    Eur J Pharmacol; 2003 Oct; 479(1-3):199-212. PubMed ID: 14612150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements.
    Corera AT; Costentin J; Bonnet JJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):213-21. PubMed ID: 10997723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic regulation of the dopamine transporter.
    Mortensen OV; Amara SG
    Eur J Pharmacol; 2003 Oct; 479(1-3):159-70. PubMed ID: 14612147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cations affect [3H]mazindol and [3H]WIN 35,428 binding to the human dopamine transporter in a similar fashion.
    Wu Q; Coffey LL; Reith ME
    J Neurochem; 1997 Sep; 69(3):1106-18. PubMed ID: 9282933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.
    Kahlig KM; Galli A
    Eur J Pharmacol; 2003 Oct; 479(1-3):153-8. PubMed ID: 14612146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
    Chen N; Zhen J; Reith ME
    J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
    Bonnet JJ; Benmansour S; Amejdki-Chab N; Costentin J
    Eur J Pharmacol; 1994 Jan; 266(1):87-97. PubMed ID: 8137886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex ionic control of [3H]GBR 12783 binding to the dopamine neuronal carrier.
    Héron C; Billaud G; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1996 Apr; 301(1-3):195-202. PubMed ID: 8773464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter as target for drug development of cocaine dependence medications.
    Dutta AK; Zhang S; Kolhatkar R; Reith ME
    Eur J Pharmacol; 2003 Oct; 479(1-3):93-106. PubMed ID: 14612141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake.
    Chen N; Trowbridge CG; Justice JB
    J Pharmacol Exp Ther; 1999 Sep; 290(3):940-9. PubMed ID: 10454463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential.
    Chen N; Reith ME
    J Neurochem; 2004 May; 89(3):750-65. PubMed ID: 15086531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Na(+) required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?
    Li LB; Cui XN; Reith MA
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):303-11. PubMed ID: 11919655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
    Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.
    Lin Z; Wang W; Uhl GR
    Mol Pharmacol; 2000 Dec; 58(6):1581-92. PubMed ID: 11093799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic interactions at the human dopamine transporter reveal binding conformations for dopamine distinguishable from those for the cocaine analog 2 alpha-carbomethoxy-3 alpha-(4-fluorophenyl)tropane.
    Chen N; Sun L; Reith ME
    J Neurochem; 2002 Jun; 81(6):1383-93. PubMed ID: 12068085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
    Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
    Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice.
    Huotari M; Santha M; Lucas LR; Karayiorgou M; Gogos JA; Männistö PT
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1309-16. PubMed ID: 12438556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter.
    Chen N; Appell M; Berfield JL; Reith ME
    Eur J Pharmacol; 2003 Oct; 478(2-3):89-95. PubMed ID: 14575792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.